Schizophrenia and the Pineal Gland

Altschule M. D. : Some effects of aqueous extracts of acetone — dried beef-pineal substance in chronic schizophrenia. New Eng. J. Med. 257: 919-922, 1957.

Ban T. A. , and Lehmann H. E. : Skin pigmentation, a rare side effect of chlorpromazine. Canad. Psychiat. Ass. J. 10: 112–124 (April) 1965.

Barnes G. J. , and Cameron M. E. : Skin and eye changes associated with chlorpromazine therapy. Med. J. Aust. 1: 478 (March 19) 1966.

Barsa J. A. , and Saunders J. C. : A peculiar photosensitivity reaction with chlorpromazine. Psychopharmacologia 7: 138, 1965.

Bertalanffy L. : in Chronic Schizophrenia; Ed. Appleby L. The Free Press of Glencoe, Ill. 1960, page 37.

Bleuler E. : Lehrbuch der Psychiatry, 1920.

Blois M. S. , Zahlan A. B. , and Maling J. E. : Electron spin resonance studies on melanin. Biophys. J. 4: 471, 1964.

Blois M. S. : From — The Origin of Pre-biological Systems and their Molecular Matrices. Acad. Press 1965, page 19–37.

Bolt A. G. , and Forrest I. S. : Metabolic studies of chlorpromazine induced hyper-pigmentation of the skin in psychiatric patients. Agressologie (Paris) IX: 2: 201-209, 1968.

Cairns R. J. , Capoore H. S. , and Gregory I. D. R. : Oculocutaneous changes after years on high doses of chlorpromazine. Lancet 1: 239, 1965.

Cameron M. E. : Ocular melanosis with special reference to chlorpromazine. Brit. J. Ophthal. 51: 295-305, 1967.

Chauvire E. , Rives H. , and Beaujard M. : Incident nouveaux des traitments de longue duree par les derives phenothiazines Actualite de Therapeutique Psychiatrique; Masson Ed. 351–373, 1967.

Chlorpromazine melanosis: Leading Article. Brit. Med. J. 630–631, 1967.

Commoner B. , and Fernberg J. L. : Free radicals in surviving tissues. Proc. Nat. Acad. Sci., Vol. 47: 1374–1384, 1961.

Cornell W. B. : Cyanosis in dementia praecox. J.A.M.A. 59: 2208–2210. 1912.

Delong S. L. , Poley B. J. , and McFarlane J. R. : Ocular changes associated with long-term chlorpromazine therapy. Arch. Ophthal. 73: 611, 1965.

Dencker S. J. , and Enoksson P. : Ocular changes produced by chlorpromazine. Acta. Ophthal. Vol. 44: 397-403, 1966.

Edler K. : Ocular changes associated with chlorpromazine therapy. Acta Ophthal Vol. 44: 405-409, 1966.

Feldman P. E. , and Friesen B. D. : Dermatological and ophtalmological changes associated with prolonged chlorpromazine therapy. Amer. J. Psychiat. 121, 187, 1964.

Fellman J. H. : Epinephrine metabolites and pigmentation in central nervous system in case of phenylpyruric oligophrenics. J. Neurol. Neurosurg. Psychiat. 21: 58-62, 1958.

Foley J. M. and Baxter D. : On the nature of pigment granules in the cells of the locus coeruleus and substantia nigra. J. Neuropath. Exp. Neurol. 17: 586-598, 1958.

Foley J. M. , and Baxter D. : Observations on the cells of the locus coeruleus and substantia nigra. J. Neuropath. Exp. Neurol. 15: 219-220, 1956.

Forrest I. S. , Green D. E. , and Udale B. P. : In vivo metabolism of chlorpromazine. Proc. Western Pharm. Soc. 7: 35, 1964.

Fraenkel G. , Hirshon J. M. , and Walling C. : Detection of polymerization radicals by paramagnetic resonance. J. Amer. Chem. Soc. 76: 3606, 1954.

Green D. E. , and Forrest I. S. : In vivo metabolism of chlorpromazine. Canad. Psychiat. Ass. J., Vol. II: 299–302, 1966.

Greiner A. C. , and Berry K. : Skin pigmentation and lens opacities with prolonged chlorpromazine therapy. Canad. Med. Ass. J. 90: 663-665, 1964.

Greiner A. C. , and Nicolson G. A. : Pigment deposition in viscera associated with chlorpromazine therapy: Canad. Med. Ass. J. 91: 627-635, 1964.

Greiner A. C. , Farmer J. B. , and Chase W. H. : Unpublished Data.

Greiner A. C. : Phenothiazines and diffuse melanosis. Agressologie (Paris) IX: 2, 1968.

Greiner A. C. , and Nicolson G. A. : Schizophrenia melanosis. Lancet II: 1165–1167, 1965.

Greiner A. C. , Nicolson G. A. , and Baker R. A. : Therapy of chlorpromazine melanosis. Canad. Med. Ass. J. 91: 636-638, 1964.

Greiner A. C. : Data not yet published.

Gunby B. , Sandvig K. , and Steenfeldt-Foss D. W. : Late oculocutaneous complications in phenothiazine therapy. Acta. Psychiat. Scand. 42: 97-110, 1966.

Hashimoto K. , Wiener W. , Albert J. , and Nelson R. G. : An electron microscopic study of chlorpromazine pigmentation. J. Invest. Derm. 47: 296-306, 1966.

Hayes G. B. , Lyle C. B. , and Wheeler C. E. : Slate-grey colour in patients receiving chlorpromazine. Arch. Derm. 90: 471, 1964.

Heimann P. : Ultrastructure of human thyroid. Acta. Endocrin. Suppl. 110, Vol. 53.

Helmy F. M. , and Hack M. H. : Comparative histochemistry of liver (amphiuma and rat) and the melanin pigment cell system of amphiuma liver. Acta. Histochem. 18: 194-212, 1964.

Karremann G. , Isenberg I. , and Szent-Gyorgyi A. : On the mechanism of action of chlorpromazine. Science 130:1191, 1959.

Kitay J. I. , and Altschule M. D. : The Pineal Gland. Cambridge, Harvard University Press, 1954.

Lerner A. B. : Hormonal control of pigmentation. Amer. Rev. Med. 1960, 11: 187.

Malamos B. , Miras C. J. , Karli-Samouilidon J. N. , and Koutras D. A. : The serum tyrosine level as an index of thyroid function. J. Endocrinol. 35:223, 1966.

Mason H. S. : The chemistry of melanin III: mechanism of the oxidation of dehydroxyphenylalanine by tyrosinase. J. Biol. Chem. 172: 83, 1948.

Massey L. W. C. : Skin pigmentation, corneal and lens opacities with prolonged chlorpromazine treatment. Canad. Med. Ass. J. 92: 186-187, 1965.

McDonald C. J. , Snell R. S. , and Lerner A. B. : The effect of chlorpromazine on oculocutaneous pigmentation in the guinea pig. J. Invest. Derm. 49: 39-42, 1967.

McDonald C. J. : Data not yet published.

McIsaac W. M. , Khairallah P. A. , and Page I. H. : 10 — Methoxy-harmalan, potent serotonin antagonist which affects conditioned behaviour. Science 134: 674-675, 1961.

Methalone M. B. R. : Oculocutaneous effects of chlorpromazine. Lancet 2: III, 1965.

Methalone M. B. R. : Eye and skin changes in psychiatric patients treated with chlorpromazine. Brit. J. Ophthal. 51: 86-93, 1967.

Nicolaus R. A. : Biogenesis of melanin. Rassegna de Medicine speriment, 1962, Suppl. 1.

Nicolaus R. A. , and Piatelli M. : Progress in the chemistry of natural black pigment. Rend, dell Accademia di Scienze in Napoli, Serie 4, Vol. XXXII, 1965.

Nicolson G. A. , Greiner A. C. , McFarlane W. J. G. , and Baker R. A. : Effect of penicillamine on schizophrenic patients. Lancet 1: 344-347, 1966.

Perrott and Bourjala : Un visage mauve. Bull. Soc. Franc. Derm. Syph. 69: 631, 1962.

Perry T. L. , Culling C. F. A. , Berry K. , and Hansen S. : 7-Hydroxychlorpromazine: potential toxic drugs, metabolite in psychiatric patients. Science 146: 81, 1964.

Piette L. H. , Bulow G. , Yamazaki I. : Electron-paramagnetic resonance studies of the chlorpromazine free radical formed during enzymic oxidation by peroxidasehydrogen peroxides. Biochem. Biophys. Acta 88: 120-129, 1964.

Prien R. F. , and Cole J. O. : High dose chlorpromazine therapy in chronic schizophrenia. Arch. Gen. Psychiat. 18: 482. 1968.

Pullman B. : Aspects de la structure electronique des phenothiazines. Agressologie (Paris) XI — 1: 19-23, 1968.

Raper H. S. : The aerobin oxidases. Physiol. Rev. 8: 245-282, 1928.

Rickards D. A. : The therapeutic effect of melatonin on canine melanosis. J. Invest. Derm. 44: 13-16, 1965.

Rivlin R. S. , Melmon K. J. , and Sjoerdsma A. : An oral tyrosine tolerance test in thyrotoxicosis and myxoedema. New Eng. J. Med. 272: 1143, 1965.

Satanove A. : Pigmentation due to phenothiazines in high and prolonged dosage. J. A. M. A. 191: 263-268, 1965.

Saunders J. C. : Psychopharmacological Frontiers. Boston, Mass. Little, Brown, and Co. 1959, page 408.

Seljelid R. : J. Ultrastructure Res. 13: 1, 1966.

Shattock F. M. : The somatic manifestations of schizophrenia. J. Ment. Sci. 46: 32-142, 1950.

Siddall J. R. : The ocular toxic finding with prolonged and high dosage chlorpromazine intake. Arch. Ophthal. 74: 460-464, 1965.

Siersback-Nielson K. : Determination of plasma tyrosine in thyroid disorders. Acta. Med. Scand. 179: 417-426, 1966.

Szent-Gyorgyi A. : Introduction to a Sub-molecular Biology. Acad. Press, New York, 1960, pages 111–114.

Tredici L. M. , Schiele B. C. , and McClanahan W. S. : The incidence and management of chlorpromazine. Minnesota Med. 569–574, 1967.

Wassermann H. P. : Extension of the concept ‘vertebrate epidermal melanin unit’ to embrace visceral pigmentation and leucocytic melanin transport. Nature 213: 282-283, 1967.

Wetterholm D. , Snow H. , and Winter F. C. : A clinical study of pigmentary change in cornea and lens in chronic chlorpromazine therapy. Invest. Ophthal. 3: 680, 1964.

Williams R. H. : Textbook of Endocrinology; Ed. W. B. Saunders, Philadelphia, Pa., U.S.A., 1968, page 703.

Wolleman M. , and Laborit H. : The action of phenothiazine and some pyridazone derivatives on respiratory enzymes in vivo and in vitro. Agressologie (Paris) IX — 1: 91-97, 1968.

Woolley D. W. , and Shaw E. : A biochemical and pharmacological suggestion about certain mental disorders. Proc. Nat. Acad. Sci. 40: 228, 1954.

Wyard S. J. : Electron spin resonance spectroscopy of animal tissues. Proc. Roy. Soc. (London) A. 302: 355, 1968.

Zelickson A. S. , and Zeller H. S. : A new and unusual reaction to chlorpromazine. J. A. M. A. 188: 388–396, 1964.

Zelickson A. S. : Skin pigmentation and chlorpromazine. J. A. M. A. 194: 670-672, 1965.

Zelickson A. S. : Skin changes and chlorpromazine. J. A. M. A. 198: 341-344, 1966.